By Gina Shaw
More than half of patients with positive cultures for bloodstream infections achieved optimal therapy within 48 hours using the Biofire Blood Culture Identification 2 (BCID2; bioMérieux) panel, a rapid multiplex polymerase chain reaction–based diagnostic platform, in a single-center retrospective cohort study presented at MAD-ID 2025, in Orlando, Fla.
The study, conducted at Brigham and Women’s Hospital, in Boston, included hospitalized adult patients with at least